Page last updated: 2024-11-02

pd 98059 and Granulocytic Leukemia

pd 98059 has been researched along with Granulocytic Leukemia in 16 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research Excerpts

ExcerptRelevanceReference
"Cotylenin A has been isolated as a plant growth regulator."1.31Induction of the monocytic differentiation of myeloid leukaemia cells by cotylenin A, a plant growth regulator. ( Asahi, KI; Honma, Y; Ishii, Y; Tomoyasu, S; Yamada, K; Yamamoto-Yamaguchi, Y, 2001)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (18.75)18.2507
2000's13 (81.25)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanson, DA1
Ziegler, SF1
Mora-Garcia, P1
Pan, R1
Sakamoto, KM1
Senga, T1
Iwamoto, T1
Humphrey, SE1
Yokota, T1
Taparowsky, EJ1
Hamaguchi, M1
Siddiqui, FA1
Siddiqui, TF1
Francis, JL1
Traore, K1
Sharma, RB1
Burek, CL1
Trush, MA1
Barge, RM1
Dorrestijn, J1
Falkenburg, JH1
Willemze, R1
Maassen, JA1
Kang, CD1
Do, IR1
Kim, KW1
Ahn, BK1
Kim, SH1
Chung, BS1
Jhun, BH1
Yoo, MA1
Birkenkamp, KU1
Esselink, MT1
Kruijer, W1
Vellenga, E1
Ajenjo, N1
Aaronson, DS1
Ceballos, E1
Richard, C1
León, J1
Crespo, P1
Baines, P1
Fisher, J1
Truran, L1
Davies, E1
Hallett, M1
Hoy, T1
Burnett, AK1
Quentmeier, H1
Dirks, WG1
Fleckenstein, D1
Zaborski, M1
Drexler, HG1
Honma, Y2
Ishii, Y2
Kasukabe, T1
Okabe-Kado, J1
Yamamoto-Yamaguchi, Y2
Kakegawa, T1
Awaya, A1
Stadheim, TA2
Xiao, H1
Eastman, A1
Yamada, K1
Asahi, KI1
Tomoyasu, S1
Koschmieder, S1
Hofmann, WK1
Kunert, J1
Wagner, S1
Ballas, K1
Seipelt, G1
Hoelzer, D1
Ottmann, OG1
Kalina, U1
Kucera, GL1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Protocol to Obtain Blood Samples for Leukemia Research[NCT00889031]187 participants (Actual)Observational2009-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

16 other studies available for pd 98059 and Granulocytic Leukemia

ArticleYear
Regulation of ionomycin-mediated granule release from rat basophil leukemia cells.
    Molecular immunology, 2002, Volume: 38, Issue:16-18

    Topics: Animals; Basophils; Butadienes; Cell Degranulation; Drug Synergism; Enzyme Inhibitors; Flavonoids; I

2002
G-CSF regulation of SRE-binding proteins in myeloid cells.
    Leukemia, 2002, Volume: 16, Issue:11

    Topics: Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Enzyme Inhibitors; Flavonoids; Granul

2002
Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells.
    Oncogene, 2002, Nov-21, Volume: 21, Issue:53

    Topics: Animals; Basic-Leucine Zipper Transcription Factors; Cell Division; DNA-Binding Proteins; Enzyme Inh

2002
Hemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:5

    Topics: Carcinoma; Cycloheximide; Enzyme Inhibitors; Flavonoids; Genistein; Hemoglobins; Humans; Leukemia, M

2003
Role of ROS and MAPK in TPA-induced ICAM-1 expression in the myeloid ML-1 cell line.
    Journal of cellular biochemistry, 2007, Mar-01, Volume: 100, Issue:4

    Topics: Blotting, Western; Butadienes; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Flavono

2007
Unconventional rapid Erk1,2 activation is indispensable for proliferation of the growth factor-independent myeloid leukemic cell line KG1.
    Leukemia, 1998, Volume: 12, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Calcium-Calmodulin-Depe

1998
Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells.
    Experimental & molecular medicine, 1999, Jun-30, Volume: 31, Issue:2

    Topics: Androstadienes; Benzoquinones; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; E

1999
Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
    European cytokine network, 1999, Volume: 10, Issue:4

    Topics: Acute Disease; Cell Division; DNA; DNA-Binding Proteins; Flavonoids; Humans; I-kappa B Proteins; Imi

1999
Myeloid leukemia cell growth and differentiation are independent of mitogen-activated protein kinase ERK1/2 activation.
    The Journal of biological chemistry, 2000, Mar-10, Volume: 275, Issue:10

    Topics: Cell Differentiation; Cell Division; Enzyme Activation; Flavonoids; Humans; Leukemia, Myeloid; Lysop

2000
The MEK inhibitor, PD98059, reduces survival but does not block acute myeloid leukemia blast maturation in vitro.
    European journal of haematology, 2000, Volume: 64, Issue:4

    Topics: Acute Disease; Adult; Aged; bcl-2-Associated X Protein; Calcium-Calmodulin-Dependent Protein Kinases

2000
Tumor necrosis factor-alpha-induced proliferation requires synthesis of granulocyte-macrophage colony-stimulating factor.
    Experimental hematology, 2000, Volume: 28, Issue:9

    Topics: Apoptosis; Cell Division; Cytokines; Enzyme Inhibitors; Flavonoids; Granulocyte-Macrophage Colony-St

2000
Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives.
    Experimental hematology, 2001, Volume: 29, Issue:2

    Topics: Calcitriol; Cell Differentiation; Cell Division; Enzyme Activation; Enzyme Inhibitors; Flavonoids; G

2001
Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.
    Cancer research, 2001, Feb-15, Volume: 61, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase Inhibitors; Cell Cycle; Drug Synergism; Enzyme

2001
Induction of the monocytic differentiation of myeloid leukaemia cells by cotylenin A, a plant growth regulator.
    British journal of haematology, 2001, Volume: 112, Issue:3

    Topics: Androstadienes; Antineoplastic Agents; Biomarkers; Cell Differentiation; Diterpenes; Enzyme Inhibito

2001
TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Acute Disease; Adult; Antigens, CD34; Cell Division; Disease Progression; DNA Replication; DNA-Bindi

2001
c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for mitoxantrone- and anisomycin-induced apoptosis in HL-60 cells.
    Leukemia research, 2002, Volume: 26, Issue:1

    Topics: Anisomycin; Antineoplastic Agents; Apoptosis; Blotting, Western; DNA, Neoplasm; Flavonoids; HL-60 Ce

2002